1195944-92-3

Basic information

• Product Name: 3-[2-(3-bromo-phenyl)-ethoxy]-4-methoxy-benzoic acid methyl ester
• Synonyms: 3-[2-(3-bromo-phenyl)-ethoxy]-4-methoxy-benzoic acid methyl ester
• CAS NO: 1195944-92-3
• Molecular Weight: 365.224
• Mol File: 1195944-92-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[2-(3-bromo-phenyl)-ethoxy]-4-methoxy-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[2-(3-bromo-phenyl)-ethoxy]-4-methoxy-benzoic acid methyl ester(1195944-92-3)
• EPA Substance Registry System: 3-[2-(3-bromo-phenyl)-ethoxy]-4-methoxy-benzoic acid methyl ester(1195944-92-3)

Safety Data

• Hazardous Substances Data: 1195944-92-3(Hazardous Substances Data)

Upstream product

• 6702-50-7 3-hydroxy-4-methoxybenzoate 
• 28229-69-8 2-(3-bromophenyl)ethan-1-ol 

Downstream Products

• 1195944-93-4 3-[2-(3-cyano-phenyl)-ethoxy]-4-methoxy-benzoic acid methyl ester 
• 1195944-94-5 3-[2-(3-cyano-phenyl)-ethoxy]-4-methoxy-benzoic acid 

Relevant articles and documents

ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

The present invention relates to compounds of the formula (I), wherein A, Y, Z, R3 to R6, R20 to R22 and R50 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. Specifically, they are inhibitors of the endothelial differentiation gene receptor 2 (Edg-2, EDG2), which is activated by lysophosphatidic acid (LPA) and is also termed as LPA1 receptor, and are useful for the treatment of diseases such as atherosclerosis, myocardial infarction and heart failure, for example. The invention furthermore relates to processes for the preparation of the compounds of the formula (I), their use and pharmaceutical compositions comprising them.